Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel.".
Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel.".